The future of liposomal chemotherapy looks promising with ongoing research and development. Advances in nanotechnology and biotechnology are expected to further improve liposome design, making them more efficient and targeted. Combination therapies, where liposomal drugs are used alongside other treatments like immunotherapy, are also being explored to enhance cancer treatment outcomes.
